10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2019 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 14, 2020) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Revenues: | |||
| Premiums | $ 189,699 | 178,087 | 158,453 |
| Products | 31,597 | 29,601 | 26,366 |
| Services | 18,973 | 17,183 | 15,317 |
| Investment and other income | 1,886 | 1,376 | 1,023 |
| Total revenues | 242,155 | 226,247 | 201,159 |
| Operating costs: | |||
| Medical costs | 156,440 | 145,403 | 130,036 |
| Operating costs | 35,193 | 34,074 | 29,557 |
| Cost of products sold | 28,117 | 26,998 | 24,112 |
| Depreciation and amortization | 2,720 | 2,428 | 2,245 |
| Total operating costs | 222,470 | 208,903 | 185,950 |
| Earnings from operations | 19,685 | 17,344 | 15,209 |
| Interest expense | (1,704) | (1,400) | (1,186) |
| Earnings before income taxes | 17,981 | 15,944 | 14,023 |
| Provision for income taxes | (3,742) | (3,562) | (3,200) |
| Net earnings | 14,239 | 12,382 | 10,823 |
| Earnings attributable to noncontrolling interests | (400) | (396) | (265) |
| Net earnings attributable to UnitedHealth Group common shareholders | 13,839 | 11,986 | 10,558 |
| Earnings per share attributable to UnitedHealth Group common shareholders: | |||
| Basic | 14.55 | 12.45 | 10.95 |
| Diluted | 14.33 | 12.19 | 10.72 |
| Basic weighted-average number of common shares outstanding | 951 | 963 | 964 |
| Dilutive effect of common share equivalents | 15 | 20 | 21 |
| Diluted weighted-average number of common shares outstanding | 966 | 983 | 985 |
| Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | 10 | 6 | 5 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2019 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 14, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Net earnings | $ 14,239 | 12,382 | 10,823 |
| Other comprehensive income (loss): | |||
| Gross unrealized gains (losses) on investment securities during the period | 1,212 | (294) | 209 |
| Income tax effect | (279) | 67 | (72) |
| Total unrealized gains (losses), net of tax | 933 | (227) | 137 |
| Gross reclassification adjustment for net realized gains included in net earnings | (104) | (62) | (83) |
| Income tax effect | 24 | 14 | 30 |
| Total reclassification adjustment, net of tax | (80) | (48) | (53) |
| Total foreign currency translation losses | (271) | (1,242) | (70) |
| Other comprehensive income (loss) | 582 | (1,517) | 14 |
| Comprehensive income | 14,821 | 10,865 | 10,837 |
| Comprehensive income attributable to noncontrolling interests | (400) | (396) | (265) |
| Comprehensive income attributable to UnitedHealth Group common shareholders | 14,421 | 10,469 | 10,572 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2019 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 14, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Operating activities | |||
| Net earnings | $ 14,239 | 12,382 | 10,823 |
| Noncash items: | |||
| Depreciation and amortization | 2,720 | 2,428 | 2,245 |
| Deferred income taxes | 230 | 42 | (965) |
| Share-based compensation | 697 | 638 | 597 |
| Other, net | (106) | (71) | 217 |
| Net change in other operating items, net of effects from acquisitions and changes in AARP balances: | |||
| Accounts receivable | 162 | (1,351) | (1,062) |
| Other assets | (1,563) | (750) | (630) |
| Medical costs payable | 1,221 | 1,831 | 1,284 |
| Accounts payable and other liabilities | 733 | 526 | 930 |
| Unearned revenues | 130 | 38 | 157 |
| Cash flows from operating activities | 18,463 | 15,713 | 13,596 |
| Investing activities | |||
| Purchases of investments | (18,131) | (14,010) | (14,588) |
| Sales of investments | 8,536 | 3,641 | 4,623 |
| Maturities of investments | 7,091 | 6,270 | 5,646 |
| Cash paid for acquisitions, net of cash assumed | (8,343) | (5,997) | (2,131) |
| Purchases of property, equipment and capitalized software | (2,071) | (2,063) | (2,023) |
| Other, net | 219 | (226) | (126) |
| Cash flows used for investing activities | (12,699) | (12,385) | (8,599) |
| Financing activities | |||
| Common share repurchases | (5,500) | (4,500) | (1,500) |
| Cash dividends paid | (3,932) | (3,320) | (2,773) |
| Proceeds from common stock issuances | 1,037 | 838 | 688 |
| Repayments of long-term debt | (1,750) | (2,600) | (4,398) |
| Proceeds from (repayments of) commercial paper, net | 300 | (201) | (3,508) |
| Proceeds from issuance of long-term debt | 5,444 | 6,935 | 5,291 |
| Customer funds administered | 13 | (131) | 3,172 |
| Other, net | (1,237) | (1,386) | (413) |
| Cash flows used for financing activities | (5,625) | (4,365) | (3,441) |
| Effect of exchange rate changes on cash and cash equivalents | (20) | (78) | (5) |
| Increase (decrease) in cash and cash equivalents | 119 | (1,115) | 1,551 |
| Cash and cash equivalents, beginning of period | 10,866 | 11,981 | |
| Cash and cash equivalents, end of period | 10,985 | 10,866 | 11,981 |
| Supplemental cash flow disclosures | |||
| Cash paid for interest | 1,627 | 1,410 | 1,133 |
| Cash paid for income taxes | 3,542 | 3,257 | 4,004 |
| Supplemental schedule of non-cash investing activities | |||
| Common stock issued for acquisitions | 0 | 0 | 2,164 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
UNITEDHEALTH GROUP INC | ||
Ticker: UNH Fiscal Year: 2019 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2019 10-K (Filed: Feb 14, 2020) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2019 | Dec 31, 2018 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 10,985 | 10,866 |
| Short-term investments | 3,260 | 3,458 |
| Accounts receivable, net of allowances of $947 and $712 | 11,822 | 11,388 |
| Other current receivables, net of allowances of $859 and $502 | 9,640 | 6,862 |
| Assets under management | 3,076 | 3,032 |
| Prepaid expenses and other current assets | 3,851 | 3,086 |
| Total current assets | 42,634 | 38,692 |
| Long-term investments | 37,209 | 32,510 |
| Property, equipment and capitalized software, net of accumulated depreciation and amortization of $4,995 and $4,141 | 8,704 | 8,458 |
| Goodwill | 65,659 | 58,910 |
| Other intangible assets, net of accumulated amortization of $5,072 and $4,592 | 10,349 | 9,325 |
| Other assets | 9,334 | 4,326 |
| Total assets | 173,889 | 152,221 |
| Liabilities, redeemable noncontrolling interests and equity | ||
| Current liabilities: | ||
| Medical costs payable | 21,690 | 19,891 |
| Accounts payable and accrued liabilities | 19,005 | 16,705 |
| Commercial paper and current maturities of long-term debt | 3,870 | 1,973 |
| Unearned revenues | 2,622 | 2,396 |
| Other current liabilities | 14,595 | 12,244 |
| Total current liabilities | 61,782 | 53,209 |
| Long-term debt, less current maturities | 36,808 | 34,581 |
| Deferred income taxes | 2,993 | 2,474 |
| Other liabilities | 10,144 | 5,730 |
| Total liabilities | 111,727 | 95,994 |
| Commitments and contingencies (Note 12) | ||
| Redeemable noncontrolling interests | 1,726 | 1,908 |
| Equity: | ||
| Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding | 0 | 0 |
| Common stock, $0.01 par value - 3,000 shares authorized; 948 and 960 issued and outstanding | 9 | 10 |
| Additional paid-in capital | 7 | 0 |
| Retained earnings | 61,178 | 55,846 |
| Accumulated other comprehensive loss | (3,578) | (4,160) |
| Nonredeemable noncontrolling interests | 2,820 | 2,623 |
| Total equity | 60,436 | 54,319 |
| Total liabilities, redeemable noncontrolling interests and equity | 173,889 | 152,221 |
| External Links | |
| UNITEDHEALTH GROUP INC (UNH) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |